Search

Author/Creator Petrie Mark investigator.

1. A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF). (21st March 2019)

Authors:
McMurray, John J.V.; DeMets, David L.; Inzucchi, Silvio E.; Køber, Lars; Kosiborod, Mikhail N.; Langkilde, Anna M.; Martinez, Felipe A.; Bengtsson, Olof; Ponikowski, Piotr; Sabatine, Marc S.; Sjöstrand, Mikaela; Solomon, Scott D.
Other Names:
McMurray John JV investigator.; DeMets David L investigator.; Inzucchi Silvio E investigator.; Køber Lars investigator.; Kosiborod Mikhail N investigator.; Langkilde Anna Maria investigator.; Martinez Felipe A investigator.; Ponikowski Piotr investigator.; Sabatine Marc S investigator.; Sjöstrand...
Journal:
European journal of heart failure
Issue:
Volume 21:Number 5(2019)
Page Start:
665
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial. (16th July 2019)

Authors:
Packer, Milton; Butler, Javed; Filippatos, Gerasimos S.; Jamal, Waheed; Salsali, Afshin; Schnee, Janet; Kimura, Karen; Zeller, Cordula; George, Jyothis; Brueckmann, Martina; Anker, Stefan D.; Zannad, Faiez
Other Names:
investigator.; Packer Milton investigator.; Anker Stefan D. investigator.; Butler Javed investigator.; Filippatos Gerasimos investigator.; Zannad Faiez investigator.; George Jyothis investigator.; Brueckmann Martina investigator.; investigator.; Perrone Sergio investigator.; Nicholls Stephen in...
Journal:
European journal of heart failure
Issue:
Volume 21:Number 10(2019)
Page Start:
1270
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial. (16th September 2019)

Authors:
Anker, Stefan D.; Butler, Javed; Filippatos, Gerasimos S.; Jamal, Waheed; Salsali, Afshin; Schnee, Janet; Kimura, Karen; Zeller, Cordula; George, Jyothis; Brueckmann, Martina; Zannad, Faiez; Packer, Milton
Other Names:
Packer Milton investigator.; Anker Stefan D. investigator.; Butler Javed investigator.; Filippatos Gerasimos S. investigator.; Zannad Faiez investigator.; George Jyothis investigator.; Brueckmann Martina investigator.; Perrone Sergio investigator.; Nicholls Stephen investigator.; Janssens Stefan ...
Journal:
European journal of heart failure
Issue:
Volume 21:Number 10(2019)
Page Start:
1279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search